Pulse pressure (PP) and ambulatory arterial stiffness index (AASI) can be calculated from ambulatory blood pressure (BP) monitoring (ABPM) and have been suggested as markers of arterial stiffness and predictors of cardiovascular mortality. We retrospectively evaluated PP and AASI from ABPM records in 84 children (43 boys) with diabetes mellitus type-1 (DMT1) compared with 27 non-diabetic normotensive children. Based on office BP and ABPM, patients with DMT1 were divided into three groups: 24/84 (29%) had hypertension (DM HTN), 33/84 (39%) were normotensive (DM NT) and 27/84 (32%) had white-coat hypertension (DM WCH). DM WCH and DM HTN patients had significantly higher PP when compared with DM NT and NT patients alone (47.62 ± 7.31 and 47.43 ± 8.68 versus 41.45 ± 4.44 and 42.18±5.97, respectively, P ¼ 0.0002). Similarly, AASI was significantly elevated in both DM WCH and DM HTN patients when compared with NT patients (0.35 ± 0.14 and 0.36 ± 0.15 versus 0.23 ± 0.15, respectively, P ¼ 0.007). In conclusion, children with DMT1 and hypertension, including WCH, had significantly higher PP and AASI levels when compared with normotensive patients. This suggests that these children may be at an increased risk for developing cardiovascular complications later on in life.
Introduction
Adult patients with diabetes mellitus type-1 (DMT1) often suffer from cardiovascular complications due to arterial hypertension and increased vascular stiffness, which may go undetected until signs of vascular pathology become clinically evident. 1 Therefore, efforts have been made to detect subclinical signs of vascular dysfunction at an earlier age/stage of development in order to prevent cardiovascular complications in patients with DMT1.
2,3
Direct non-invasive assessment of vascular function is possible with pulse-wave velocity (PWV) measurement. [3] [4] [5] However, in children and adolescents this technique is mostly used for research purposes. 4 Therefore, attempts have been made to use ambulatory BP monitoring (ABPM) for indirect assessment of vascular stiffness.
Ambulatory pulse pressure (PP) calculated from ABPM has been used as a good surrogate of vascular stiffness and has been associated with cardiovascular mortality. 6 Recently, ambulatory arterial stiffness index (AASI) has been proposed as a surrogate measure of arterial stiffness. 7, 8 Both the PP and AASI essentially represent the relation between systolic (SBP) and diastolic BP (DBP) over 24 h and can be readily determined from ABPM. AASI closely correlates with aortic PWV 7 and is associated with target organ damage. 9 Moreover, it independently predicts cardiovascular mortality, 10 and was found to be a strong predictor of stroke. 6, 11 Increased AASI was also found in microalbuminuric adult patients with DMT1, 12 and was associated with all-cause mortality in elderly people with diabetes mellitus. 13 In children, the clinical significance of the increased PP and AASI remains to be determined. Simonetti et al.
14 reported a significantly higher AASI in children and young adults with hypertension as compared with normotensive controls, suggesting early vascular dysfunction related to hypertension. Children with DMT1 are known to have arterial hypertension (HTN), mostly at night, and a non-dipping pattern of BP. 15, 16 Children with DMT1 may therefore suffer from undetected arterial hypertension, in addition to the presence of diabetes, which can be difficult to control. 17 It would therefore be reasonable to assume that hypertensive diabetic children suffer from increased arterial stiffness developing early in the course of DMT1.
We analysed PP and AASI in a group of diabetic children in comparison with normotensive children. The purpose of the study was to determine whether PP and/or AASI were increased in children with DMT1 and sustained hypertension. We also hypothesised that even children with white-coat hypertension are at risk for developing increased arterial stiffness.
Patients and methods

Patients
We performed a retrospective chart review of all diabetic children who were referred to the nephrology clinic at the Department of Pediatrics, University Hospital Ostrava, for assessment of hypertension during the period January 2003 to September 2008. In this period, 87 patients had their ABPM completed at their initial visit without any antihypertensive therapy. Three patients were excluded from the study: one because of age (below 5 years) and two because they did not have a valid ABPM study performed (absence of night-time BP recordings). In total, 84 patients with complete ABPM records were included in the final analysis.
All patients had usual physical activity and normal diet.
Classification of diabetic patients
Based on ABPM results analysed, 18 the diabetic patients (n ¼ 84) were classified as having normotension (DM NT) if their office and ambulatory BP were normal (n ¼ 33); white-coat hypertension (DM WCH) if their office BP was X95th percentile but ambulatory BP was normal (n ¼ 27); true hypertension if their office BP and ambulatory BP were X95th percentile (n ¼ 16); masked hypertension if their daytime ambulatory BP was X95th percentile but office BP was normal (n ¼ 3) and isolated nighttime hypertension if their night-time ambulatory BP was X95th percentile but office BP was normal (n ¼ 5). Patients with masked and isolated nighttime hypertension were considered at risk for complications from hypertension, similarly to patients with true hypertension, and were therefore included in the same group as true hypertensive patients and subsequently classified as hypertensive patients (DM HTN) (n ¼ 24). The patients' characteristics are shown in Table 1 .
Control group
The control group (NT) consisted of 27 patients. Nine patients suffered from headache or syncope and 18 patients had, or previously suffered from, various types of kidney disease, including the following: microscopic haematuria (n ¼ 5), transient proteinuria (n ¼ 3), status post tubulointerstitial nephritis (n ¼ 3), post unilateral nephrectomy for multicystic dysplastic kidney disease (n ¼ 3), minimal change nephrotic syndrome in long-term remission (n ¼ 1), post anaphylactoid purpura (n ¼ 1) and autosomal polycystic kidney disease (n ¼ 2). All patients from the control group had normal renal function and had no significant proteinuria (Table 1) . These patients were referred to the nephrology clinic during the same time period in order to rule out ambulatory hypertension or hypotension. All patients had normal office BP and normotension was subsequently confirmed on ABPM. These patients were not treated with any antihypertensive medications at the time of ABPM.
Methods
At the time of ABPM measurements, the following parameters were recorded: body height, weight and office BP. The body mass index (BMI) was calculated 
Laboratory investigations
Glycosylated haemoglobin (HBA1C), serum creatinine, glomerular filtration rate calculated by Schwartz et al. 19 and albumin-to-creatinine ratio in morning spot urine were investigated at the time of ABPM. HBA1C was determined by high-performance liquid chromatography (PDQ; Primus Diagnostics, Kansas City, MO, USA). Serum and urine creatinine were determined by standardised biochemical (Jaffé) methods. Albumin in the urine was measured by the immune-nephelometric method (Immage; Beckman Coulter, Inc., Fullerton, CA, USA) and pathological microalbuminuria was defined as albumin-to-creatinine ratio 42.2 mg mmol
À1
.
Office BP measurement
According to current guidelines, 20 office BP was measured on the same day as the ABPM (before initiating the ABPM device) on the right arm using an automatic oscillometric Omron M4-I device (Omron Health Care Europe BV, 's-Hertogenbosch, The Netherlands). The obtained absolute values were subsequently converted into SDS according to normative data for age, height and sex. 20 As per definition, patients with SBP and DBP values below the 90th percentile for age, height and sex were regarded as normotensive; patients with SBP or DBP, or both BP values between the 90th and the 95th percentiles or 4120/80 mm Hg were considered as having high normal BP (pre-hypertensive); and patients with SBP or DBP or both BP values X95th percentile were defined as hypertensive.
Twenty-four-hour ABPM ABPM was performed using the oscillometric device SpaceLabs 90217 (SpaceLabs Medical Inc., Redmond, WA, USA). The monitor was programmed to measure the BP every 20 min during the day (0600-2200 hours) and every 30 min during night (2400-0600 hours). Parents and children were instructed to keep a diary of daily activities during the ABPM measurement. However, in order to compare our results with the normative values for ABPM, we defined the daytime period as 0800-2000 hours and the night-time period as 1200-1800 hours 18 The cuff size was determined by measurement of mid-arm circumference and was approximately 40% of the arm circumference; the cuff was placed on the non-dominant arm. The patients were instructed to avoid vigorous physical exercise during their ABPM measurement, but to follow their usual daily activities. A minimum of 40 ABPM recordings were required to consider the ABPM as valid.
For analysis of ABPM results, we used the Chronos-Fit software (version 1.05; P Zuther and B Lemmer, Chronos-Fit; http://www.abpm-fit.de). The following linear ABPM parameters were analysed: mean arterial pressure (MAP), SBP, DBP and BP load over 24 h, during daytime and night time. The average absolute values for MAP, SBP and DBP for all time periods were subsequently converted into SDS values using the most recent normative values. 18 Night-time BP dipping was calculated using the ratio of mean daytime/mean night time of MAP, SBP and DBP. Non-dipping (absence of nocturnal BP fall of at least 10%) was defined as day/night ratio o1.1 in MAP and/or SBP and/or DBP. The BP loads were analysed based on the average BP load (MAP, SBP, DBP) for any given time period separately.
BP load was defined as the percentage of valid ambulatory BP measures above a set threshold value, such as the 95th percentile of BP for gender and height. The highest load from any given time period measured for MAP, SBP and DBP was considered as the maximum BP load.
Definition of normotension/hypertension on ABPM Patients were considered as normotensive if their average MAP, SBP and DBP during 24 h, daytime and night-time periods were below 1.645 SDS (95th percentile) regardless of the BP load and dipping/ non-dipping. Consequently, if one of the BP parameters (MAP, SBP or DBP) during 24 h or during the daytime or night-time periods was above 1.645 SDS, the patient was labelled as hypertensive on ABPM, regardless of the BP load and dipping status.
Ambulatory PP PP was calculated from ABPM as the average of the differences between individual SBP and DBPs recorded over 24 h.
Ambulatory arterial stiffness index
Using individual 24-h BP readings, DBP was plotted against SBP and a linear regression slope was calculated; the slope was not forced through the origin. AASI was then calculated as 1Àregression slope. 7 AASI was considered to be valid if the regression analysis was significant (Po0.05); if there were more than 20 readings per sampling period and if there were more than 18 continuous hours with valid readings present.
Statistical analysis
Data are shown as mean±s.d. if normally distributed or median and inter-quartile range (25th and 75th percentile) in cases of non-normal distribution. Continuous variables in patient groups were compared by analysis of variance with Bonferroni correction for multiple comparisons (normally Arterial stiffness in children with diabetes mellitus type-1 T Šuláková et al distributed data), or Kruskal-Wallis test with Dunn's multiple comparisons correction (not normally distributed data). Categorical variables (proportion of patients between groups) were compared by w 2 -test. Using standard power calculation at a confidence level of 80%, the minimum sample size for each subgroup is 31 patients. In order to overcome the smaller sample size in some of our subgroups, we added confidence intervals to Table 3 .
Cumulative distribution curves were constructed for PP and AASI.
Multiple regression analysis was performed to analyse the correlation between PP/AASI and various other demographic and BP parameters.
Results were considered statistically significant if the P-value was below 0.05. All statistical analyses were performed using the GraphPad Prism software, version 5.0 (GraphPad Software, La Jolla, CA, USA).
The study was approved by the local hospital ethics committee.
Results
The basic characteristics of the study population are given in Table 1 . Age, gender distribution and BMI SDS were not statistically different between the groups (Table 1) . Out of 111 children (all study and control patients) only seven patients were obese (BMI X95th percentile) and 11 were overweight (BMI 485 but o95th percentile). The prevalence of overweight/obesity in subgroups was as follows: 2/2 in DM NT, 3/1 in DM WCH, 4/0 in DM HTN and 2/4 in NT. There were no significant differences in the proportion of overweight/obese children among the sub-groups. The DM HTN patients had a significantly longer duration of diabetes when compared with DM NT and DM WCH patients (Po0.03). No statistical differences between groups were found in the metabolic control of diabetic children, renal function and microalbuminuria (Table 1) .
ABPM results
ABPM results are shown in Table 2 . Out of 24 diabetic patients with hypertension (DM HTN) only one (4%) patient had isolated daytime hypertension, 14/24 (58%) had isolated nocturnal hypertension and 9/24 (38%) patients had day-and night-time hypertension. Five out of 24 (20.8%) DM HTN patients had isolated systolic hypertension, 8/24 (33.3%) had isolated diastolic hypertension and 7/24 (29.2%) had both systolic and diastolic hypertension. Hypertensive diabetic children (DM HTN) had significantly higher values of 24-h, day-and night-time MAP, SBP and DBP when compared with normotensive patients (DM NT), white-coat diabetics (DM WCH) and normotensive control subjects (NT). Even though DM WCH patients had ambulatory normotension, their 24-h, day-and night-time MAP, SBP and night-time DBP values were significantly higher in comparison with the NT group.
The MAP day/night ratio was significantly lower in patients with DM HTN when compared with DM Arterial stiffness in children with diabetes mellitus type-1 T Šuláková et al NT and NT patients alone ( Table 2 ). The NT patients were all dippers (100%) in comparison with the diabetic groups, but the lowest proportion of dippers (54%) was found in DM HTN (P ¼ 0.0009).
On the contrary, DM HTN patients had the highest max. BP load (P ¼ 0.0001). No significant differences in any of the heart rate parameters were found between subgroups. There was an only weak correlation between the 24-h heart rate variability and AASI (r ¼ 0.036, P ¼ 0.047).
Markers of arterial stiffness PP and AASI are shown in Table 3 . Patients with DM WCH and DM HTN had significantly higher PP compared with DM NT and NT patients. Similarly, AASI was significantly elevated in both DM WCH and DM HTN patients when compared with NT patients (Table 3; Figure 1) .
Using a cut-off point for AASI higher than 0.301 for distinguishing normotensive from hypertensive children and young adults, 14 the prevalence of abnormal/higher AASI was as follows: 45% in DM NT, 59% in DM WCH, 67% in DM HTN and 33% in NT patients (Figure 1) . Out of 16 patients with DM HTN and AASI40.3, 11 had isolated night-time hypertension and five had combined day-and nighttime hypertension.
The cumulative distribution curves of PP and AASI showed a shift to the right in patients with DM HTN and DM WCH (Figure 2) , indicating a greater proportion of patients with a higher PP/AASI when compared with the DM NT and NT groups.
Multiple regression analysis showed a significant correlation between PP and age (r ¼ 0.37, Pp0.001), 
Discussion
The main findings of our study are as follows: (a) children with DMT1 and sustained arterial hypertension had higher PP and AASI than normotensive children, suggesting increased arterial stiffness; and (b) similar results were found in children with DMT1 and white-coat hypertension.
Increased arterial stiffness has been associated with increased risk of cardiovascular events in adult patients, 21 and usually precedes the development of structural vascular changes. 22 Therefore, early detection and treatment of increased arterial stiffness may prevent future development of structural vascular changes. 23 Arterial stiffness can be directly measured by PWV. 4, 5, 24 However, PWV measurement requires a specific device, a quiet patient and good normative values. It is therefore not surprising that PWV has been predominantly used for research purposes. In clinical practice, a more available and simpler method of vascular stiffness assessment has been explored.
With the advent of ABPM, ambulatory PP has been used for indirect assessments of arterial stiffness. 25 PP is calculated as the difference between individual SBP and DBP values s on ABPM and correlated well with arterial stiffness assessed by aortic PWV. 26 In contrast to initial reports on the association between PP and cardiovascular mortality, 25 PP did not carry any prognostic information on cardiovascular mortality in recent studies. 6 On the other hand, PP predicted the progression of albuminuria in elderly people with type-2 diabetes, 27 and was found to have a reasonable reproducibility. 28 The controversies about the utility of PP in clinical practice prompted the search of other noninvasive markers of arterial stiffness. Recently, AASI has been proposed as a surrogate measure of arterial stiffness in both adults and children. 7, 14 Similarly to PP, AASI reflects the relation between SBP and DBP. In contrast to PP, AASI is a more refined measure reflecting the dynamic relationship between SBP and DBP over a wide range of BP values. It can be The more rigid the vessels are, the lower the slope that will be obtained, which in turn yields a higher AASI. In adults, an increased AASI is associated with target organ damage in primary hypertension, 9 and is a good predictor of cardiovascular morbidity and mortality. 6, 29 In children, only limited data on AASI are available. Simonetti et al.
14 described a higher AASI in children with primary and secondary hypertension when compared with healthy controls. In that study, AASI correlated well with PP and duration of hypertension in children. 14 Few studies exist on the use of PP and AASI in diabetic patients. Palmas et al. 27 studied PP and AASI in elderly people with diabetes mellitus and concluded that PP outperformed AASI in predicting progression of albuminuria. More recently, the same author concluded that AASI improved the prediction of risk of mortality in patients with diabetes. 13 Laugesen et al. found increased AASI and PP in microalbuminuric adult patients with DMT1, compared with healthy controls. Furthermore, nocturnal BP reduction and SBP daytime BP variability were found to be the determinants of AASI. 12 We found higher PP and AASI in hypertensive children with DMT1 when compared with normotensive children. Our results are in line with a recent study by Urbina et al. 5 who found increased arterial stiffness in children and young people with DMT1, measured by PWV with BP, being an important determinant of increased arterial stiffness. In that study, patients with DMT1 had a higher office BP and PP than healthy controls, suggesting that some of the diabetic patients suffered from hypertension; the comparison between hypertensive and normotensive diabetics was not reported, 5 thus this prohibits direct comparison with our study. Our data also cannot be directly compared with the results of Laugesen et al. 12 as it is not clear how many patients had hypertension in the microalbuminuric group. However, all BP average values were significantly higher in the microalbuminuric group compared with the normoalbuminuric group. 12 This would suggest that there was a higher prevalence of hypertensive patients in the microalbuminuric group who also had a higher AASI. AASI was indeed associated with both diurnal BP variation and BP variability. 12 Our data also show a significant correlation between the AASI and MAP dipping.
It seems therefore that higher BP and BP variability may be a risk factor for obtaining a higher AASI in both adults and children with DMT1. As DMT1 and hypertension coexist in the same individuals for many years, it is logical to assume that Arterial stiffness in children with diabetes mellitus type-1 T Šuláková et al a longer duration of either DMT1 or hypertension, or both, would have a significant impact on vascular health. From this perspective, it seems important that a higher AASI is already present in young hypertensive diabetic children. This is similar to hypertensive children without diabetes as already described by Simonetti et al. 14 Interestingly, AASI was similar in hypertensive children without diabetes (mean AASI ¼ 0.37 ± 0.12) compared with our diabetic hypertensive children (mean AASI ¼ 0.36 ± 0.15). In addition, the distribution of AASI shifted to the right in both non-diabetic hypertensive 14 and diabetic hypertensive (our study) children. AASI correlated well with PP in both studies. In addition, our data show a similar shift to the right in the cumulative distribution of PP (as seen with AASI).
In non-diabetic hypertensive children, higher AASI correlated with duration of hypertension. 14 In our study, the duration of hypertension cannot be established due to the cross-sectional type of the study and the unknown beginning of hypertension in children with diabetes. However, diabetic children with hypertension had a significantly longer duration of diabetes, with a weak but significant correlation between duration and AASI. Although both PP and AASI correlated with patients' age, this should not have a significant impact on study results as there were no significant age differences among subgroups.
Interestingly enough, even patients with whitecoat hypertension had a higher AASI and PP, with a similar shift to the right in cumulative distribution, comparable to patients with sustained hypertension. This would suggest that diabetic patients with WCH have a similar risk for developing vascular dysfunction as patients with sustained hypertension. This is similar to non-diabetic children in whom presence of white-coat hypertension has been associated with similar end-organ damage as in patients with sustained hypertension. 30, 31 Moreover, the presence of white-coat hypertension is associated with a higher risk of developing microalbuminuria and sustained hypertension in adult patients with DMT1. 32 Therefore, children with DMT1 and white-coat hypertension may have an increased risk of developing cardiovascular complications later in life, similarly to patients with sustained hypertension.
Limitations of the study First and foremost, it is a cross-sectional study of children with variable durations of DMT1 and variable durations of white-coat or sustained hypertension. Therefore, it is impossible to separate the impact that hypertension and diabetes have on PP or AASI. Second, PP and AASI are only surrogate markers of vascular stiffness and were not compared with PWV measurements in our study. Literature reports suggest that AASI and PWV correlate well, but should not be considered interchangeable. 33 AASI is a mathematical calculation derived from ABPM results, subject to possible errors/artefacts on ABPM recordings and interpretation problems with the AASI (impact of BP dipping). 34 We chose not to use symmetrical AASI, as there are no paediatric data available and there are ongoing discussions as to which formula should be used. Third, the relatively small number of patients enrolled is yet another limitation of the study.
Conclusion
PP and AASI can be derived from ABPM data as surrogate markers of arterial stiffness. We found that these markers are significantly elevated in diabetic children with white-coat and sustained hypertension. These children may therefore be at risk for cardiovascular complications later in life.
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